Sanara MedTech Inc. (SMTI)
NASDAQ: SMTI · Real-Time Price · USD
37.07
-0.22 (-0.58%)
Nov 21, 2024, 2:19 PM EST - Market open
Sanara MedTech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 78.06 | 64.99 | 45.84 | 24.14 | 15.59 | 11.77 | Upgrade
|
| Revenue Growth (YoY) | 24.66% | 41.77% | 89.87% | 54.90% | 32.47% | 34.02% | Upgrade
|
| Cost of Revenue | 7.68 | 7.85 | 6.36 | 2.31 | 1.62 | 1.21 | Upgrade
|
| Gross Profit | 70.38 | 57.14 | 39.48 | 21.83 | 13.97 | 10.56 | Upgrade
|
| Selling, General & Admin | 69.12 | 57.43 | 46.09 | 28.26 | 18.67 | 13.07 | Upgrade
|
| Research & Development | 3.51 | 3.7 | 3.07 | 0.36 | 0.04 | - | Upgrade
|
| Operating Expenses | 77.04 | 64.8 | 51.53 | 29.21 | 19 | 13.3 | Upgrade
|
| Operating Income | -6.66 | -7.67 | -12.05 | -7.38 | -5.03 | -2.74 | Upgrade
|
| Interest Expense | -2.13 | -0.48 | - | -0 | -0.01 | -0.11 | Upgrade
|
| Earnings From Equity Investments | -0.03 | - | -0.38 | -0.62 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | 0.01 | 0.01 | Upgrade
|
| EBT Excluding Unusual Items | -8.82 | -8.14 | -12.43 | -7.99 | -5.03 | -2.84 | Upgrade
|
| Merger & Restructuring Charges | -0.83 | - | -0.19 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.25 | 0.25 | -1.04 | - | - | - | Upgrade
|
| Other Unusual Items | 0.92 | 3.45 | -0.28 | - | 0.59 | - | Upgrade
|
| Pretax Income | -8.47 | -4.44 | -13.94 | -7.99 | -4.45 | -2.84 | Upgrade
|
| Income Tax Expense | - | - | -5.84 | - | - | - | Upgrade
|
| Earnings From Continuing Operations | -8.47 | -4.44 | -8.09 | -7.99 | -4.45 | -2.84 | Upgrade
|
| Minority Interest in Earnings | 0.11 | 0.14 | 0.15 | 0.07 | 0.09 | 0.02 | Upgrade
|
| Net Income | -8.36 | -4.3 | -7.94 | -7.92 | -4.36 | -2.81 | Upgrade
|
| Net Income to Common | -8.36 | -4.3 | -7.94 | -7.92 | -4.36 | -2.81 | Upgrade
|
| Shares Outstanding (Basic) | 8 | 8 | 8 | 7 | 6 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 8 | 8 | 8 | 7 | 6 | 2 | Upgrade
|
| Shares Change (YoY) | 2.85% | 4.71% | 7.70% | 28.02% | 168.88% | -1.79% | Upgrade
|
| EPS (Basic) | -0.99 | -0.52 | -1.00 | -1.08 | -0.76 | -1.32 | Upgrade
|
| EPS (Diluted) | -0.99 | -0.52 | -1.00 | -1.08 | -0.76 | -1.32 | Upgrade
|
| Free Cash Flow | -1.99 | -3.51 | -5.7 | -4.99 | -4.58 | -2.35 | Upgrade
|
| Free Cash Flow Per Share | -0.24 | -0.42 | -0.72 | -0.68 | -0.80 | -1.10 | Upgrade
|
| Gross Margin | 90.16% | 87.92% | 86.12% | 90.43% | 89.63% | 89.72% | Upgrade
|
| Operating Margin | -8.53% | -11.79% | -26.28% | -30.55% | -32.30% | -23.29% | Upgrade
|
| Profit Margin | -10.71% | -6.62% | -17.31% | -32.81% | -27.95% | -23.92% | Upgrade
|
| Free Cash Flow Margin | -2.55% | -5.40% | -12.44% | -20.65% | -29.38% | -19.97% | Upgrade
|
| EBITDA | -2.25 | -3.99 | -9.67 | -6.78 | -4.74 | -2.62 | Upgrade
|
| EBITDA Margin | -2.89% | -6.14% | -21.10% | -28.08% | -30.43% | -22.27% | Upgrade
|
| D&A For EBITDA | 4.41 | 3.68 | 2.37 | 0.6 | 0.29 | 0.12 | Upgrade
|
| EBIT | -6.66 | -7.67 | -12.05 | -7.38 | -5.03 | -2.74 | Upgrade
|
| EBIT Margin | -8.53% | -11.79% | -26.28% | -30.55% | -32.30% | -23.29% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.